Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-12 Sale | 2024-09-16 8:50 pm | Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer | 88,657 | $4.3022 | $381,423 | 808,921 (Direct) | View |
| 2024-09-12 Sale | 2024-09-16 8:49 pm | Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer | 16,149 | $4.3022 | $69,477 | 92,826 (Indirect Direct) | View |
| 2024-09-12 Sale | 2024-09-16 8:48 pm | Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel | 30,926 | $4.3022 | $133,051 | 219,061 (Direct) | View |
| 2024-09-12 Sale | 2024-09-16 8:47 pm | Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer | 28,286 | $4.3022 | $121,693 | 89,285 (Direct) | View |
| 2024-09-12 Sale | 2024-09-16 8:46 pm | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 148,110 | $4.3022 | $637,203 | 50,475 (Direct) | View |
| 2024-08-22 Sale | 2024-08-23 6:13 pm | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 105,244 | $4.4298 | $466,210 | 30,000 (Direct) | View |
| 2024-06-25 Sale | 2024-06-27 4:15 pm | Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel | 46,389 | $3.4853 | $161,678 | 184,387 (Direct) | View |
| 2024-06-25 Sale | 2024-06-27 4:15 pm | Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer | 24,224 | $3.4853 | $84,427 | 62,975 (Indirect Direct) | View |
| 2024-06-25 Sale | 2024-06-27 4:15 pm | Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer | 42,429 | $3.4853 | $147,876 | 57,571 (Direct) | View |
| 2024-06-25 Sale | 2024-06-27 4:15 pm | Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer | 132,985 | $3.4853 | $463,487 | 709,518 (Direct) | View |
| 2024-06-25 Sale | 2024-06-27 4:15 pm | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 33,102 | $3.4853 | $115,369 | 34,548 (Direct) | View |
| 2024-05-22 Sale | 2024-05-23 9:54 pm | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 100,432 | $2.9651 | $297,788 | 7,650 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-11 Exercise | 2024-09-13 4:57 pm | 2024-09-11 2025-01-25 | Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel | 65,600 | $0 | 249,987 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-13 4:50 pm | 2024-09-11 2025-01-25 | Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer | 60,000 | $0 | 117,571 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-13 4:49 pm | 2024-09-11 2025-01-25 | Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer | 46,000 | $0 | 108,975 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-13 4:49 pm | 2024-09-11 2025-01-25 | Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer | 188,060 | $0 | 897,578 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-13 4:47 pm | 2024-09-11 2025-01-25 | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 40,000 | $0 | 242,881 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-13 4:47 pm | N/A 2032-01-14 | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 93,333 | $1.4 | 242,881 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-13 4:47 pm | N/A 2033-01-25 | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 75,000 | $1.01 | 242,881 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-23 6:13 pm | N/A N/A | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 1,825 | $3 | 30,000 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-23 6:13 pm | N/A N/A | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 2,071 | $3.87 | 30,000 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-23 6:13 pm | N/A 2029-07-23 | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 173,000 | $0 | 30,000 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-23 6:13 pm | N/A N/A | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 38,953 | $1.31 | 30,000 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-23 6:13 pm | N/A N/A | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 43,485 | $0.94 | 30,000 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-23 6:13 pm | N/A N/A | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 12,418 | $2.72 | 30,000 (Direct) | View |
| 2024-08-22 Exercise | 2024-08-23 6:13 pm | N/A N/A | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 6,492 | $1.84 | 30,000 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 6:21 pm | 2024-06-21 2025-01-25 | Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer | 69,000 | $0 | 133,199 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 6:15 pm | 2024-06-21 2025-01-25 | Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer | 282,090 | $0 | 1,030,563 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 6:14 pm | 2024-06-21 2025-01-25 | Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel | 98,400 | $0 | 296,376 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 6:13 pm | 2024-06-21 2025-01-25 | Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer | 90,000 | $0 | 160,000 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 6:13 pm | 2024-06-21 2025-01-25 | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 60,000 | $0 | 107,650 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-17 5:16 pm | N/A N/A | Mereo BioPharma Group plc | MREO | Rubric Capital Management LP Rosen David Efraim 10% Owner | 1,754,350 | $3.99 | 15,307,347 (Indirect) | View |
| 2024-06-17 Option Award | 2024-06-17 4:15 pm | N/A N/A | Mereo BioPharma Group plc | MREO | WYZGA MICHAEL S Director | 25,050 | $3.99 | 25,050 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-17 4:15 pm | N/A N/A | Mereo BioPharma Group plc | MREO | Bender Jeremy Director | 12,550 | $3.99 | 12,550 (Indirect) | View |
| 2024-05-22 Exercise | 2024-05-23 9:54 pm | N/A 2032-01-14 | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 93,333 | $1.4 | 7,650 (Direct) | View |
| 2024-05-22 Exercise | 2024-05-23 9:54 pm | N/A 2033-01-25 | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 75,000 | $1.01 | 7,650 (Direct) | View |
| 2024-05-22 Tax Withholding | 2024-05-23 9:54 pm | N/A N/A | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 42,983 | $1.4 | 7,650 (Direct) | View |
| 2024-05-22 Tax Withholding | 2024-05-23 9:54 pm | N/A N/A | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 24,918 | $1.01 | 7,650 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Ekblom Anders Director | 64,471 | $0 | 64,471 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Jacquet Pierre Director | 60,553 | $0 | 60,553 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Yoskowitz Marc J Director | 59,139 | $0 | 59,139 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | WYZGA MICHAEL S Director | 75,783 | $0 | 75,783 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Shames Daniel Director | 59,139 | $0 | 59,139 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Jenkins Annalisa Director | 59,947 | $0 | 59,947 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Bender Jeremy Director | 61,361 | $0 | 61,361 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel | 245,000 | $0 | 245,000 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer | 850,000 | $0 | 850,000 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 196,000 | $0 | 196,000 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer | 137,000 | $0 | 137,000 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer | 245,000 | $0 | 245,000 (Direct) | View |
Ownership | 2024-01-02 4:20 pm | N/A N/A | Mereo Biopharma Group plc | MREO | Ekblom Anders Director | 0 | $0 | 369,948 (Indirect) | View |